tiprankstipranks
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
India Market
SUNPHARMA
Sun Pharmaceutical Industries Limited
RESEARCH TOOLSreports

Sun Pharmaceutical Industries Limited (SUNPHARMA) Financial Statements

Compare
0 Followers

Sun Pharmaceutical Industries Limited Financial Overview

Sun Pharmaceutical Industries Limited's market cap is currently ₹3.82T. The company's EPS TTM is ₹47.653; its P/E ratio is 33.45; and it has a dividend yield of 0.85%. Sun Pharmaceutical Industries Limited is scheduled to report earnings on January 31, 2025, and the estimated EPS forecast is ₹10.79. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 477.58B₹ 432.79B₹ 384.26B₹ 331.39B₹ 323.25B
Gross Profit₹ 229.46B₹ 326.17B₹ 267.19B₹ 232.54B₹ 218.54B
Operating Income₹ 104.68B₹ 93.05B₹ 81.47B₹ 64.28B₹ 49.48B
EBITDA₹ 138.36B₹ 120.85B₹ 67.00B₹ 49.99B₹ 73.13B
Net Income₹ 95.76B₹ 84.74B₹ 32.73B₹ 29.04B₹ 37.65B
Balance Sheet
Cash & Short-Term Investments₹ 193.29B₹ 159.07B₹ 126.55B₹ 95.63B₹ 109.40B
Total Assets₹ 854.63B₹ 807.44B₹ 698.00B₹ 676.67B₹ 682.52B
Total Debt₹ 32.74B₹ 68.90B₹ 12.90B₹ 38.69B₹ 83.15B
Net Debt₹ -60.12B₹ 22.66B₹ -32.18B₹ -24.04B₹ 26.38B
Total Liabilities₹ 183.57B₹ 214.28B₹ 187.34B₹ 181.87B₹ 191.28B
Stockholders' Equity₹ 636.67B₹ 559.95B₹ 480.11B₹ 464.63B₹ 452.64B
Cash Flow
Free Cash Flow₹ 99.33B₹ 28.74B₹ 74.89B₹ 50.00B₹ 50.13B
Operating Cash Flow₹ 121.35B₹ 49.59B₹ 89.85B₹ 61.70B₹ 65.55B
Investing Cash Flow₹ -6.90B₹ -79.44B₹ -57.25B₹ 5.36B₹ -25.89B
Financing Cash Flow₹ -67.10B₹ 23.76B₹ -51.93B₹ -59.80B₹ -57.15B
Currency in INR

Sun Pharmaceutical Industries Limited Earnings and Revenue History

Sun Pharmaceutical Industries Limited Debt to Assets

Sun Pharmaceutical Industries Limited Cash Flow

Sun Pharmaceutical Industries Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis